EUVIMEDEUVIMED entdecken
Open Access

Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 US States, 2004–2023

Veena Ramachandran iD, Jennifer Onukwube Okaro iD, Namrata Prasad iD, Soyoun Park iD, Lesley McGee, Sopio Chochua iD, Yuan Li iD, Bridget J Anderson iD, Kari E Burzlaff, Lee H Harrison iD, Terresa Carter, Jessica Houston und 15 weitere

Clinical Infectious Diseases · 2026

DOI: 10.1093/cid/ciag284 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2026. Verfasst von Veena Ramachandran und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georg…. Hauptthemen laut MEDLINE: Streptococcal Infections, Streptococcus pyogenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS, Centers for Disease Control and Prevention Emerging Infections Program's.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Group A Streptococcus (GAS) infections are common in children, ranging from mild to life-threatening invasive disease. Large-scale descriptions of changes in pediatric invasive GAS infections in the United States, particularly during the coronavirus disease 2019 (COVID-19) pandemic, are limited.

Methods

We used the Centers for Disease Control and Prevention’s (CDC's) Active Bacterial Core surveillance (ABCs), a multistate, population- and laboratory-based surveillance system, to assess changes in pediatric (<18 years old) invasive GAS incidence, clinical presentation, and bacterial strain characteristics from 2004 to 2023. Interrupted time series analysis was used to compare observed versus expected GAS incidence during 2020–2023, informed by trends before the COVID-19 pandemic (2004–2019).

Results

During 2004–2023, 2856 invasive GAS cases were identified. Incidence remained stable from 2004 to 2019 (mean incidence 1.9 per 100 000), decreased in 2020 (1.0) and 2021 (0.6), and rebounded in 2022 (1.5) and 2023 (4.4). ICU admission increased from 2011 to 2023; case fatality remained stable. Penicillin resistance was not detected. Clindamycin non-susceptibility doubled from 2011 (3.8%) to 2022 (7.5%), before slightly decreasing in 2023 (6.4%). Infections due to emm1, the most frequently identified emm type in children with severe disease, almost disappeared in 2021 but surged in late 2022.

Conclusions

After remaining stable for more than a decade, pediatric invasive GAS incidence declined during the COVID-19 pandemic and rebounded in 2022, more than doubling 2004–2019 incidence in 2023. Although case fatality remained low, intensive care unit (ICU) admissions increased over time, highlighting the need for effective preventive measures such as vaccines. Increasing clindamycin non-susceptibility bears continued monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Streptococcal InfectionsStreptococcus pyogenesHumansUnited StatesIncidenceChildChild, PreschoolAdolescentFemaleInfantAnti-Bacterial AgentsMaleCOVID-19

Stichwörter der Autor:innen

United Statesepidemiologygroup A Streptococcusinvasive bacterial diseasepediatrics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • NewYork State Department of Health, Albany, New York, USA.
  • Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • New Mexico Emerging Infections Program, New Mexico Department of Health, Santa Fe, New Mexico, USA.
  • Minnesota Department of Health, St.Paul, Minnesota, USA.

ORCID-Profile: Veena Ramachandran, Jennifer Onukwube Okaro, Namrata Prasad, Soyoun Park, Sopio Chochua, Yuan Li, Bridget J Anderson, Lee H Harrison, Kayla Fails, Jennifer Zipprich, Maria Rosales, Shua J Chai, William Schaffner, Tiffanie M Markus, Jessica Howard-Anderson, Meghan Barnes, Erin Youngkin, Christopher J Gregory

Förderung

  • Intramural CDC HHS
  • Centers for Disease Control and Prevention Emerging Infections Program's

Zitieren

APA

Ramachandran, V., Onukwube Okaro, J., Prasad, N., Park, S., McGee, L., Chochua, S., Li, Y., Anderson, B. J., Burzlaff, K. E., Harrison, L. H., Carter, T., Houston, J., Sosin, D. M., Fails, K., Zipprich, J., Petit, S., Rosales, M., Chai, S. J., Schaffner, W., …, & Gregory, C. J. (2026). Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 US States, 2004–2023. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciag284

Vancouver

Ramachandran V, Onukwube Okaro J, Prasad N, Park S, McGee L, Chochua S, et al. Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 US States, 2004–2023. Clinical Infectious Diseases. 2026. doi:10.1093/cid/ciag284

BibTeX
@article{Ramachandran2026,
  author = {Ramachandran, Veena and Onukwube Okaro, Jennifer and Prasad, Namrata and Park, Soyoun and McGee, Lesley and Chochua, Sopio and Li, Yuan and Anderson, Bridget J and Burzlaff, Kari E and Harrison, Lee H and Carter, Terresa and Houston, Jessica and Sosin, Daniel M and Fails, Kayla and Zipprich, Jennifer and Petit, Susan and Rosales, Maria and Chai, Shua J and Schaffner, William and Markus, Tiffanie M and Thomas, Ann and Martin, Tasha and Tunali, Amy and Howard-Anderson, Jessica and Barnes, Meghan and Youngkin, Erin and Gregory, Christopher J},
  title = {Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 US States, 2004–2023},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  doi = {10.1093/cid/ciag284}
}
Kostenlos starten →